New Leaf Venture Management Iii, L.l.c. - Net Worth and Insider Trading
New Leaf Venture Management Iii, L.l.c. Net Worth
The estimated net worth of New Leaf Venture Management Iii, L.l.c. is at least $50 Million dollars as of 2024-11-13. New Leaf Venture Management Iii, L.l.c. is the 10% Owner of Deciphera Pharmaceuticals Inc and owns about 1,963,258 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $50 Million. New Leaf Venture Management Iii, L.l.c. is also the 10% Owner of Aptinyx Inc and owns about 368,345 shares of Aptinyx Inc (APTX) stock worth over $35,361. Details can be seen in New Leaf Venture Management Iii, L.l.c.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that New Leaf Venture Management Iii, L.l.c. has not made any transactions after 2019-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of New Leaf Venture Management Iii, L.l.c.
New Leaf Venture Management Iii, L.l.c. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, New Leaf Venture Management Iii, L.l.c. owns 6 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) , Harpoon Therapeutics Inc (HARP) , and Arvinas Inc (ARVN) among others .
Insider Ownership Summary of New Leaf Venture Management Iii, L.l.c.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2019-08-16 | 10 percent owner |
| HARP | Harpoon Therapeutics Inc | 2021-01-11 | 10 percent owner |
| ARVN | Arvinas Inc | 2018-09-26 | 10 percent owner |
 | | 2018-06-25 | 10 percent owner |
| | 2018-05-24 | 10 percent owner |
| | 2016-06-21 | director |
New Leaf Venture Management Iii, L.l.c. Latest Holdings Summary
New Leaf Venture Management Iii, L.l.c. currently owns a total of 2 stocks. Among these stocks, New Leaf Venture Management Iii, L.l.c. owns 1,963,258 shares of Deciphera Pharmaceuticals Inc (DCPH) as of August 16, 2019, with a value of $50 Million and a weighting of 99.93%. New Leaf Venture Management Iii, L.l.c. also owns 368,345 shares of Aptinyx Inc (APTX) as of June 25, 2018, with a value of $35,361 and a weighting of 0.07%.
Latest Holdings of New Leaf Venture Management Iii, L.l.c.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2019-08-16 | 1,963,258 | 25.59 | 50,239,772 |
| APTX | Aptinyx Inc | 2018-06-25 | 368,345 | 0.10 | 35,361 |
Holding Weightings of New Leaf Venture Management Iii, L.l.c.
New Leaf Venture Management Iii, L.l.c. Form 4 Trading Tracker
According to the SEC Form 4 filings, New Leaf Venture Management Iii, L.l.c. has made a total of 0 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years. The most-recent trade in Deciphera Pharmaceuticals Inc is the sale of 350,000 shares on August 16, 2019, which brought New Leaf Venture Management Iii, L.l.c. around $13 Million.
According to the SEC Form 4 filings, New Leaf Venture Management Iii, L.l.c. has made a total of 0 transactions in Aptinyx Inc (APTX) over the past 5 years. The most-recent trade in Aptinyx Inc is the acquisition of 250,000 shares on June 25, 2018, which cost New Leaf Venture Management Iii, L.l.c. around $4 Million.
Insider Trading History of New Leaf Venture Management Iii, L.l.c.
- 1
New Leaf Venture Management Iii, L.l.c. Trading Performance
GuruFocus tracks the stock performance after each of New Leaf Venture Management Iii, L.l.c.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by New Leaf Venture Management Iii, L.l.c. is 35.65%. GuruFocus also compares New Leaf Venture Management Iii, L.l.c.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by New Leaf Venture Management Iii, L.l.c. within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how New Leaf Venture Management Iii, L.l.c.'s insider trading performs compared to the benchmark.
Performance of New Leaf Venture Management Iii, L.l.c.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.25 | | | | | |
| Relative Return to S&P 500(%) | -3.63 | | | | | |
New Leaf Venture Management Iii, L.l.c. Ownership Network
Ownership Network List of New Leaf Venture Management Iii, L.l.c.
Ownership Network Relation of New Leaf Venture Management Iii, L.l.c.
New Leaf Venture Management Iii, L.l.c. Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
New Leaf Venture Management Iii, L.l.c. is the 10 percent owner of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include EVP & Chief Medical Officer Matthew L Sherman , Chief Financial Officer Thomas Patrick Kelly , and Chief Commercial Officer Daniel C. Martin .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, New Leaf Venture Management Iii, L.l.c. made no insider transaction in Deciphera Pharmaceuticals Inc (DCPH). Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 23,797 shares made by Daniel C. Martin , a net sale of 12,184 shares made by Matthew L Sherman , and a net sale of 9,198 shares made by Thomas Patrick Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 105,002 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 95,002 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
New Leaf Venture Management Iii, L.l.c. Mailing Address
Above is the net worth, insider trading, and ownership report for New Leaf Venture Management Iii, L.l.c.. You might contact New Leaf Venture Management Iii, L.l.c. via mailing address: C/o New Leaf Venture Partners, 7 Times Square, Suite 3502, New York Ny 10036.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
